Onderneming Karyopharm Therapeutics Inc.
Aandelen
KPTI
US48576U1060
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,17 USD | -8,59% | -4,10% | +35,26% |
Vakgebied
Aantal werknemers: 325
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drugs
100,0
%
| 157 | 100,0 % | 146 | 100,0 % | -7,03% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 157 | 100,0 % | 146 | 100,0 % | -7,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 26-02-20 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 25-02-19 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-23 |
Accumanno James
CMP | Compliance Officer | - | 01-05-21 |
Reshma Rangwala
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-04-22 |
Elhan Webb
IRC | Investor Relations Contact | - | 14-03-22 |
Lisa DiPaolo
HRO | Human Resources Officer | - | 01-09-22 |
Stuart Poulton
PRN | Corporate Officer/Principal | 51 | 01-02-22 |
Sohanya Cheng
PRN | Corporate Officer/Principal | 41 | 08-06-21 |
Michael Mano
LAW | General Counsel | 47 | 15-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 03-10-13 |
Barry Greene
BRD | Director/Board Member | 60 | 01-01-13 |
Director/Board Member | 59 | 01-04-13 | |
Chen Schor
BRD | Director/Board Member | 51 | 25-11-20 |
Mansoor Mirza
BRD | Director/Board Member | 63 | 01-10-10 |
Richard Paulson
CEO | Chief Executive Officer | 56 | 26-02-20 |
Christy Oliger
BRD | Director/Board Member | 54 | 28-08-20 |
Su Zhen
BRD | Director/Board Member | 47 | 31-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 116 465 736 | 109 492 351 ( 94,01 %) | 0 | 94,01 % |
Bedrijfsgegevens
Karyopharm Therapeutics, Inc.
85 Wells Avenue Suite 210, 2nd floor
02459-3298, Newton
+617 658 0600
http://www.karyopharm.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,26% | 136 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,37 mld. | |
-1,80% | 21,37 mld. | |
-17,75% | 20,92 mld. | |
-6,91% | 18,64 mld. | |
-42,00% | 16,4 mld. | |
-28,19% | 13,53 mld. | |
+19,90% | 10,85 mld. | |
-23,23% | 8,4 mld. |
- Beurs
- Aandelen
- Koers KPTI
- Onderneming Karyopharm Therapeutics Inc.